NextCure downgraded by Ladenburg Thalmann

11/4/22 1:03:13 PM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Ladenburg Thalmann downgraded NextCure from Buy to Neutral

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$NXTC

Date	Price Target	Rating	Analyst
11/4/2022		Buy → Neutral	Ladenburg Thalmann
3/1/2022	$16.00	Buy	Ladenburg Thalmann
11/5/2021	$30.00 → $14.00	Buy	Needham